Main Article Content

Faiza Inam
Rabia Ghafoor
Parisa Sanawar
Khadija Asadullah
Nazia Jabeen
Ammar Farooq


Outcome, Autologous platelet-rich plasma (PRP), Conventional Therapy, Chronic Venous Leg Ulcers


Objective: To compare the outcome of treatment with autologous platelet-rich plasma (PRP) versus conventional therapy for patients with chronic venous leg ulcers.

Methods: This randomized controlled trial was conducted at the department of Dermatology, Jinnah Postgraduate Medical Centre, Karachi from 1st September 2022 to 25th May 2023. Patients aged 30-80 years of either gender having chronic venous leg ulcer were enrolled. Patients were randomly allocated to Autologous PRP and conventional therapy group. PRP was applied after proper surgical debridement and was dressed with a non-absorbent dressing once weekly for 6 weeks. Conservative therapy was performed by compression using graduated elastic stockings below the knee and dressing using Saline and Vaseline gauze weekly for 6 weeks. Outcome was assessed in terms of complete healing, length of ulcer, and width of ulcer at 6 weeks.

Results: Of 96 patients, the mean age was 59.17 ±7.01 years. There were 53 (55.2%) females and 43 (44.8%) males. A significantly lower mean length of ulcer at 6 weeks was observed in PRP than conventional therapy patients, i.e., 2.11 ±0.88 vs. 2.97 ±0.84 (p-value <0.001). Moreover, a significant mean difference of width of ulcer at 6 weeks was observed in PRP than conventional therapy patients, i.e., i.e., 1.36 ±0.42 vs. 1.54 ±0.39 (p-value 0.037). Moreover, a significantly higher frequency of complete healing was observed in PRP than conventional therapy, i.e., 26 (54.2%) and 7 (14.6%) respectively (p-value <0.001).

Conclusion: A better outcome of PRP was observed compared to conventional therapy in patients with chronic venous leg ulcers.

Abstract 186 | PDF Downloads 84


1. Meissner MH, Gloviczki P, Bergan J, Kistner RL, Morrison N, Pannier F, Pappas PJ, Rabe E, Raju S, Villavicencio JL. Primary chronic venous disorders. J Vasc Surg. 2007;46 Suppl S:54S-67S. doi: 10.1016/j.jvs.2007.08.038.
2. Davies AH. The Seriousness of Chronic Venous Disease: A Review of Real-World Evidence. Adv Ther. 2019 Mar;36(Suppl 1):5-12. doi: 10.1007/s12325-019-0881-7.
3. Khan AF, Chaudhri R, Ashraf MA, Mazaffar MS, Zawar-ul-Imam S, Tanveer M. Prevalence and presentation of chronic venous disease in Pakistan: a multicentre study. Phlebology. 2013 Mar;28(2):74-9. doi: 10.1258/phleb.2012.011122.
4. Radhakrishnan N, George D, Jayakrishnan R, Sumi S, Kartha CC. Vein Size and Disease Severity in Chronic Venous Diseases. Int J Angiol. 2018;27(4):185-189. doi: 10.1055/s-0038-1639355.
5. Etufugh CN, Phillips TJ. Venous ulcers. Clin Dermatol. 2007;25(1):121-30. doi: 10.1016/j.clindermatol.2006.09.004.
6. Alavi A, Sibbald RG, Phillips TJ, Miller OF, Margolis DJ, Marston W, Woo K, Romanelli M, Kirsner RS. What's new: Management of venous leg ulcers: Approach to venous leg ulcers. J Am Acad Dermatol. 2016;74(4):627-40; quiz 641-2. doi: 10.1016/j.jaad.2014.10.048.
7. Cobos Campos R, Parraza Diez N, Aizpuru BF. Platelet-rich plasma in skin ulcer treatment. Wounds. 2013;25:256-62.
8. Marx RE. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent. 2001;10:225–8.
9. Singh RP, Marwaha N, Malhotra P, Dash S. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods. Asian J Transfus Sci. 2009;3(2):86-94. doi: 10.4103/0973-6247.53882.
10. Yotsu RR, Hagiwara S, Okochi H, Tamaki T. Case series of patients with chronic foot ulcers treated with autologous platelet-rich plasma. J Dermatol. 2015 Mar;42(3):288-95. doi: 10.1111/1346-8138.12777.
11. Moneib HA, Youssef SS, Aly DG, Rizk MA, Abdelhakeem YI. Autologous platelet-rich plasma versus conventional therapy for the treatment of chronic venous leg ulcers: A comparative study. J Cosmet Dermatol. 2018;17(3):495-501. doi: 10.1111/jocd.12401.
12. Miłek T, Nagraba Ł, Mitek T, Woźniak W, Mlosek K, Olszewski W, et al. Autologous Platelet-Rich Plasma Reduces Healing Time of Chronic Venous Leg Ulcers: A Prospective Observational Study. Adv Exp Med Biol. 2019;1176:109-117. doi: 10.1007/5584_2019_388.
13. Helmy Y, Farouk N, Ali Dahy A, Abu-Elsoud A, Fouad Khattab R, Elshahat Mohammed S, et al. Objective assessment of Platelet-Rich Plasma (PRP) potentiality in the treatment of Chronic leg Ulcer: RCT on 80 patients with Venous ulcer. J Cosmet Dermatol. 2021;20(10):3257-3263. doi: 10.1111/jocd.14138.
14. Aldein HA, Salib WF, Nageeb RM, Mohamed AA, Radwan AF. Autologous Platelet-rich Plasma Versus Conventional Dressing in Treatment of Chronic Venous Leg Ulcers. QJM: An International Journal of Medicine. 2021;114(Supplement_1):hcab097-002.
15. Xia Y, Zhao J, Xie J, Lv Y, Cao DS. The Efficacy of Platelet-Rich Plasma Dressing for Chronic Nonhealing Ulcers: A Meta-Analysis of 15 Randomized Controlled Trials. Plast Reconstr Surg. 2019 Dec;144(6):1463-1474. doi: 10.1097/PRS.0000000000006281.
16. Sarvajnamurthy S, Suryanarayan S, Budamakuntala L, Suresh DH. Autologous platelet rich plasma in chronic venous ulcers: study of 17 cases. J Cutan Aesthet Surg. 2013;6(2):97-9. doi: 10.4103/0974-2077.112671.
17. Deshmukh S, Fulare SM, Gupta J, Kate R, Dhamne S. Role of platelet rich plasma in chronic non-healing ulcer: An observational study. Int J Surg. 2021;5(2):145-8.
18. Yilmaz S, Aksoy E, Doganci S, Yalcinkaya A, Diken AI, Cagli K. Autologous platelet-rich plasma in treatment of chronic venous leg ulcers: A prospective case series. Vascular. 2015;23(6):580-5. doi: 10.1177/1708538114563824.
19. Martinez-Zapata MJ, Mart_ı-Carvajal AJ, Sol_a I. Autologous platelet-rich plasma for treating chronic wounds. Cochrane DatabaseSyst Rev. 2016;(5). Art. No.: CD006899.
20. Shaydakov ME, Ting W, Sadek M, Aziz F, Diaz JA, Raffetto JD, et al. Review of the current evidence for topical treatment for venous leg ulcers. J Vasc Surg Venous Lymphat Disord. 2022;10(1):241-247.e15. doi: 10.1016/j.jvsv.2021.06.010.

Most read articles by the same author(s)